The ABILITY Diabetes Global study comparing the ABLUMINUS Sirolimus eluting stent from Concept Medical to the XIENCE Everolimus Eluting stent from Abbott Vascular in diabetic patients is conducted in transatlantic cooperation between CERC and Icahn School of Medicine at Mount Sinai (NY, USA). Patient inclusion has recently begun, reaching enrollment of the first 100 patients out of a total of 3000 patients in early November.
